These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 14748439)

  • 21. Comparision of interleukin-6 and malondialdehyde levels in diabetic patients in Taiwan.
    Wen YR; Chang LP; Chen HL; Liu CF
    Diabetes Nutr Metab; 2004 Dec; 17(6):368-70. PubMed ID: 15887631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of ACE gene polymorphism on carbohydrate metabolism, on oxidative stress and on end-organ damage in type-2 diabetes mellitus].
    Molnár GA; Wagner Z; Wagner L; Melegh B; Kószegi T; Degrell P; Bene J; Tamaskó M; Laczy B; Nagy J; Wittmann I
    Orv Hetil; 2004 Apr; 145(16):855-9. PubMed ID: 15156690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination therapy with renin-angiotensin system inhibitors and the calcium channel blocker azelnidipine decreases plasma inflammatory markers and urinary oxidative stress markers in patients with diabetic nephropathy.
    Ogawa S; Mori T; Nako K; Ito S
    Hypertens Res; 2008 Jun; 31(6):1147-55. PubMed ID: 18716362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum cystatin C in diabetic patients. Not only an indicator for renal dysfunction in patients with overt nephropathy but also a predictor for cardiovascular events in patients without nephropathy.
    Ogawa Y; Goto T; Tamasawa N; Matsui J; Tando Y; Sugimoto K; Tomotsune K; Kimura M; Yasujima M; Suda T
    Diabetes Res Clin Pract; 2008 Feb; 79(2):357-61. PubMed ID: 17980929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma homocysteine, oxidative stress and endothelial function in patients with Type 1 diabetes mellitus and microalbuminuria.
    Wotherspoon F; Laight DW; Browne DL; Turner C; Meeking DR; Allard SE; Munday LJ; Shaw KM; Cummings MH
    Diabet Med; 2006 Dec; 23(12):1350-6. PubMed ID: 17116187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma and urinary vascular endothelial growth factor and diabetic nephropathy in Type 2 diabetes mellitus.
    Kim NH; Kim KB; Kim DL; Kim SG; Choi KM; Baik SH; Choi DS; Kang YS; Han SY; Han KH; Ji YH; Cha DR
    Diabet Med; 2004 Jun; 21(6):545-51. PubMed ID: 15154937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma lipid peroxidation and antioxidiant nutrients in type 2 diabetic patients.
    Peerapatdit T; Patchanans N; Likidlilid A; Poldee S; Sriratanasathavorn C
    J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S147-55. PubMed ID: 17718256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased glomerular and extracellular malondialdehyde levels in patients and rats with diabetic nephropathy.
    Chang JM; Kuo MC; Kuo HT; Chiu YW; Chen HC
    J Lab Clin Med; 2005 Oct; 146(4):210-5. PubMed ID: 16194682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of renal involvement on peripheral blood mononuclear cell expression behaviour of tumour necrosis factor-alpha and interleukin-6 in type 2 diabetic patients.
    Navarro JF; Mora C; Gómez M; Muros M; López-Aguilar C; García J
    Nephrol Dial Transplant; 2008 Mar; 23(3):919-26. PubMed ID: 17911088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevation of urinary betaig-h3, transforming growth factor-beta-induced protein in patients with type 2 diabetes and nephropathy.
    Ha SW; Kim HJ; Bae JS; Jeong GH; Chung SC; Kim JG; Park SH; Kim YL; Kam S; Kim IS; Kim BW
    Diabetes Res Clin Pract; 2004 Aug; 65(2):167-73. PubMed ID: 15223229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diabetic nephropathy: has the time come to move beyond plasma creatinine?
    Osman MM; Ahmed MH
    Ren Fail; 2006; 28(6):525-6. PubMed ID: 16928625
    [No Abstract]   [Full Text] [Related]  

  • 32. [If the level of cystatin C in children and adolescents with type 1 diabetes an early marker for diabetic nephropathy?].
    Peczyńska J; Urban M; Głowińska B; Florys B
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(3):141-6. PubMed ID: 16232367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention and treatment of diabetic nephropathy.
    Wittmann I; Molnár GA; Degrell P; Wagner Z; Tamaskó M; Laczy B; Brasnyó P; Wagner L; Nagy J
    Diabetes Res Clin Pract; 2005 Jun; 68 Suppl1():S36-42. PubMed ID: 15955373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aberrant activation profile of cytokines and mitogen-activated protein kinases in type 2 diabetic patients with nephropathy.
    Wong CK; Ho AW; Tong PC; Yeung CY; Kong AP; Lun SW; Chan JC; Lam CW
    Clin Exp Immunol; 2007 Jul; 149(1):123-31. PubMed ID: 17425653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High levels of circulating interleukin-10 in diabetic nephropathy patients.
    Myśliwska J; Zorena K; Semetkowska-Jurkiewicz E; Rachoń D; Suchanek H; Myśliwski A
    Eur Cytokine Netw; 2005 Jun; 16(2):117-22. PubMed ID: 15941682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The comparison of cystatin C and creatinine as an accurate serum marker in the prediction of type 2 diabetic nephropathy.
    Lee BW; Ihm SH; Choi MG; Yoo HJ
    Diabetes Res Clin Pract; 2007 Dec; 78(3):428-34. PubMed ID: 17822797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of oxidative stress and endothelial dysfunction in Asian Indians with type 2 diabetes mellitus with and without macroangiopathy.
    Singhania N; Puri D; Madhu SV; Sharma SB
    QJM; 2008 Jun; 101(6):449-55. PubMed ID: 18385148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diltiazem attenuates oxidative stress in diabetic rats.
    Anjaneyulu M; Chopra K
    Ren Fail; 2005; 27(3):335-44. PubMed ID: 15957552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal function preservation in type 2 diabetes mellitus patients with early nephropathy: a comparative prospective cohort study between primary health care doctors and a nephrologist.
    Martínez-Ramírez HR; Jalomo-Martínez B; Cortés-Sanabria L; Rojas-Campos E; Barragán G; Alfaro G; Cueto-Manzano AM
    Am J Kidney Dis; 2006 Jan; 47(1):78-87. PubMed ID: 16377388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Manganese superoxide dismutase gene polymorphism (V16A) is associated with stages of albuminuria in Korean type 2 diabetic patients.
    Lee SJ; Choi MG; Kim DS; Kim TW
    Metabolism; 2006 Jan; 55(1):1-7. PubMed ID: 16324912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.